|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
������� |
|
��������� |
|
������ |
|
�������Ƽ� |
| ��������������� | |
|
���� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
���߷���ָ���Է�������۵��о���չ
����, ������
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
�����߿�ͨ���յ���������ϸ�����Ӳ��������Ϳ�ԭ���ϸ���Ĺ��ܵ�;����Ƥ������������������,���������Ϊһ����Ч���㷺�Ĺ����˷�����ʩ,Ŀǰ��������۷�������Ҫ������в������ߵļ�������Ϊ��,�в���ȷ�����۷���������߷������á�
[2] Shimizu T, Streilein JW. Local and systemic consequences of acute, low-dose ultraviolet B radiation are mediated by different immune regulatory mechanisms. Eur J Immunol, 1994, 24:1765-1770.
[3] Amerio P, Toto P, Feliciani C, et al. Rethinking the role of tumour necrosis factor-alpha in ultraviolet (UV) B-induced immunosuppression:altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice. Br J Dermatol, 2001, 144:952-957.
[4] Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol, 2003, 13:515-523.
[5] Walterscheid JP, Ullrich SE, Nghiem DX. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med, 2002, 195:171-179.
[6] Nghiem DX, Kazimi N, Clydesdale G, et al. Ultraviolet a radiationsuppresses an established immune response:implications for sunscreen design. J Invest Dermatol, 2001, 117:1193-1199.
[7] Seite S, Zucchi H, Moyal D, et al. Alterations in human epidermal Langerhans cells by ultraviolet radiation:quantitative and morphological study. Br J Dermatol, 2003, 148:291-299.
[8] Poon TS, Barnetson RS, Halliday GM. Prevention of immunosup pression by sunscreens in humans is unrelated to protection fromerythema and dependent on protection from ultraviolet a in the face of constant ultraviolet B protection. J Invest Dermatol, 2003, 121:184-190.
[9] Kelly DA, Young AR, McGregor JM, et al. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med, 2000,191:561-566.
[10] Moyal DD, Fourtanier AM. Efficacy of broad-spectrum sunscreens against the suppression of elicitation of delayed-type hypersensitivity responses in humans depends on the level of ultraviolet A protection. Exp Dermatol, 2003, 12:153-159.
[11] Cooper KD, Baron ED, Matsui MS. Implications of UV-induced inflammation and immunomodulation. Cutis, 2003, 72(3 Suppl):11.
[12] Baron ED, Stevens SR. Sunscreens and immune protection. Br J Dermatol, 2002, 146:933-937.
[13] Wolf P, Hoffmann C, Quehenberger F, et al. Immune protection factors of chemical sunscreens measured in the local contact hyper sensitivity model in humans. J Invest Dermatol, 2003, 121:1080-1087.
[14] Damian DL, Barnetson RS, Halliday GM. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photo biol, 1999, 70:910-915.
[15] Cooper KD, Baron ED, LeVee G, et al. Protection against UV-induced suppression of contact hypersensitivity responses by sunscreens in humans. Exp Dermatol, 2002, 11(Suppl 1):20-27.
[16] Dumay O, Karam A, Vian L, et al. Ultraviolet AI exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen-presenting cell function:partial protection by a broadspectrum sunscreen. Br J Dermatol, 2001, 144:1161-1168.
[17] Katiyar SK. Treatment of silymarin, a plant flavonoid, prevents ul traviolet light-induced immune suppression and oxidative stress in mouse skin. Int J Oncol, 2002, 21:1213-1222.